Surveillance May Reduce CIN 2 Overtreatment - Quiz - MDSpire

Surveillance May Reduce CIN 2 Overtreatment

Risk-based management may reduce unnecessary excisions in selected patients with CIN 2.

  • By

  • Andrea Surnit

  • June 26, 2026

  • 3 min

Share

Original Source(s)

Surveillance May Reduce CIN 2 Overtreatment

  • by Andrea Surnit

  • June 26, 2026

Related Content

Severe renal and pancreatic toxicities associated with ipilimumab and nivolumab combination therapy in non-small cell lung cancer: a pharmacovigilance analysis of the FDA adverse event reporting system

Selpercatinib versus multi-kinase inhibitors for advanced medullary thyroid cancer: A network meta-analysis of RET-targeted therapies

Adrenal tumor microenvironment: hormone–immune crosstalk, molecular heterogeneity, and immunotherapeutic opportunities